Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 2/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.37 |
| ▸ | ADRA2A | P08913 | 13/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 12/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 12/20 | 0.34 |
| ▸ | ADRA1B | P35368 | 10/20 | 0.34 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27796359 | 0.71 | CYP19A1 (0.46) | CYP19A1CYP11B2ADRA2AADRA2BADRA2C | |
| SCHEMBL27254356 | 0.67 | IDO1 (0.39) | — | |
| SCHEMBL18826073 | 0.59 | HRH3 (0.52) | CYP19A1CYP11B2ADRA2AADRA2BADRA2C | |
| Hydrochloric Acid SCHEMBL9529847 | 0.58 | HRH3 (0.50) | CYP19A1CYP11B2ADRA2AADRA2BADRA2C | |
| SCHEMBL13196399 | 0.58 | ADRA2A (0.71) | CYP19A1CYP11B2ADRA2AADRA2BADRA2C | |
| SCHEMBL23259047 | 0.57 | IDO1 (0.53) | ADRA2BADRA2CADRA1A | |
| SCHEMBL9610269 | 0.57 | IDO1 (0.53) | ADRA2BADRA2CADRA1A | |
| SCHEMBL18826066 | 0.55 | CYP19A1 (0.54) | CYP19A1CYP11B2ADRA2AADRA2BADRA2C | |
| SCHEMBL7944637 | 0.55 | CYP11B2 (1.00) | CYP19A1CYP11B2ADRA2AADRA2BADRA2C | |
| SCHEMBL779556 | 0.55 | ADRA2A (0.64) | CYP19A1CYP11B2ADRA2AADRA2BADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209008-A1 | METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND | TOKYO INSTITUTE OF TECHNOLOGY (JP) | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209008-A1 | METHOD FOR PRODUCING ASYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING SYMMETRIC PHOSPHORIC ACID TRIESTER, METHOD FOR PRODUCING PHOSPHORIC ACID ESTER, AND METHOD FOR PRODUCING ORGANOPHOSPHORUS COMPOUND | HAO2, PLCB1, PHPT1 | CYP19A1 277/4885CYP11B2 776/4885ADRA2A 2142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.